Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

I am considering contacting Deltex re an update on the Hanover Freedom Of Information Request #687 Received 25/11/2009 by Email from Hanover Comms.

I wish to send this request, on behalf of myself and other investors (I may get a better chance of a reply if I mention on behalf of others). It may come to nothing but it might just mean they give Hanover a bit of a push.
So if other agree, please feel free to say so (or not) as the case may be.

Regards Greek

As I have had several requests via another site to send the aforementioned E-Mail I have done so.

My request and their reply (received within 2 working days) follows.

Dear Sir or Madam,

On behalf of several Deltex shareholders, could I request an update re the above FOI request, as it is now almost 6 months since said request was made.

According to Norfolk and Norwich University Hospitals, the request is 'Still being Processed'.

I am sure you are aware that under the FOI act, the recipient of such an enquiry has to reply within a reasonable time, we do not consider 6 months to be reasonable.

I presume Hanover Comms, is being suitably rewarded for submitting such requests.

I appreciate this information is possibly market sensitive, but the lack of a definitive reply, is effecting the SP.

Regards

David PATTENDEN.


Reply From Ewan Phillips CEO of Deltex,

As you appear to have surmised, we fired off a number of FOI requests some time ago via our PR agents. The purpose of this, at the time, was to explore whether we could build up some "insurance" in case there was a lack of response from the UK health system after the publication of the NTAC 'How to Why to' guide on Doppler guided fluid management.

Since the responses to NTAC's excellent work have been universally satisfactory with a number of related initiatives developing promisingly, we have not needed the insurance and have therefore instructed our PR agents specifically not to pursue this workstream as we no longer see advantage in it to us. We are however highly active with our public relations work - which is about far more than the odd splash in the papers: we have been running a variety of programmes for the last six years, the last four with Hanover who are excellent and very good value for money.
You are welcome to pass on the above to your correspondents.

Kind regards


Ewan


Ewan Phillips
Chief Executive - CEO
Deltex Medical Group plc

I would just like to add, that I thanked Mr Phillips and stated that I am sure anyone connected with Deltex are as frustrated as we are re the difficulty that the NHS managers have in making obvious decisions.
I feel we will have to just sit back patiently and wait.

Regards Pond.

Deltex? sounds familiar. deltex?
sorry got confused.please ignore this post...at your peril. dont add.at least not yet, if ever.
just my opinion as always and please all dyor.i could be wrong.
good luck to all.
regards
jkd

I decided a few months ago, just to 'sit' on my holdings for about a year to 18 months, as I viewed this to be the time limit for Deltex to either make it, or fail.

On reading (between the lines) the e-mail from Mr Phillips, I decided to top up a bit, as there are several indications that things are bubbling under the surface,
IE....
'Since the responses have been universally'
'With a number of related initiatives developing promisingly'
'Not needed the insurance'

May of course be throwing more money into a bottomless pot, but I do have a feeling that we will be hearing a few positives in the near future, say 3 to 4 months, and by positives I mean contracts.

I never like to post such comments without at least trying to find more solid backing than a 'feeling', but as said, read between the lines and come to you own conclusions, which of course you will anyway.

Deltex is now even more the biggest holding I have. Still big risk = big reward (or failure of course).

Regards Greek.

greekman, many thanks for your recent efforts re DEMG, it does look promising, has done for years but the sp is still not performing (yet). I still hold DEMG and hopefully will live long enough to see some reward. The CEO was quick to defend/praise Hanover.
2517

Hi George,

Agree re the quick to defend Hanover. I would like to know a bit more of how they are earning their fee.

LORD Ara Darzi, author of the NHS Next Stage Review, will be exploring the export opportunities open to UK-based medical technology companies at a conference next month.
ABHI International Business Conference will be held on 13 May 2010 - Barlow, Lyde & Gilbert, London
Other speakers will include the ABHIs chief executive, Peter Ellingworth, and industry leaders such as 'Ewan Philips of Deltex Medical'.

http://www.hesmagazine.com/show.php?page=story&id=1806&story=1806

Re todays RNS.

Not knocking the increased sales as that would be just stupid, but they were expected by all the indicators. Lets just wait for more details.
What I am looking to is the next lot of financials, with cost, profits, sales figures, hoping that momentum is increasing 'At a faster rate', proving or not whether the future prospects of the CardioQ have any real future.
I feel that the cutback in health spending, worldwide may work just as much in Deltex's favour as against, as I have read several reports over the last few months stating that Health Authorities must look at more value for money, and that they must deliver this value, something that was touched upon in todays RNS.
As we know Deltex can never be looked at as a defensive share, but with the financial climate as it is, it will in my opinion be a mix of those solid few defensive shares that earn a steady income and a few high risk shares that may just make the mega bucks that investments will need even more.
It is often said that investing in shares of those industries that we can not do without, IE we all have to eat, travel, take medication to name but three, have a continuing safeguard, but looking forward there may just come a time when the medical world looks on the CardioQ as something they just can't manage without. Once/if this gathers momentum, it will surely be a case of catch up as if the CardioQ becomes generally accepted. Patients as well as doctors/surgeons will be questioning, not why do we need it, but why haven't we got it.
Just look back to the days when heart monitors were a rarely, now it would look unusual to see a bed containing a patient who has suffered a heart attack or being observed for a heart related problem, without such a device being evident.
Heart monitors save money in the long term by early warning of problems, and the cost effective effect of earlier treatment.
Perhaps that analogy is stretching it a bit, but I think the only real hope for the CardioQ making it big, is for it to reach the stage where it becomes a must have bit of kit.

Still a few ifs out there, not with the technology which we know works and has been often proven value of cost, but in it's acceptance by those who decide where the money is spent.

Good news.
2517

yep, sure is. An increase of double the amount of probes by this one hospital, over the next 6 months.
Great news. Has the snowball started to gather pace. I believe so.

The 4 none exec directors and the 1 exec have taken shares once again in lieu of salary.

Ewan Phillips has taken share options in place of salary increase, that on a rough work out look to be about a 5th less than if he had taken cash . So he has faith that the sp will increase by at 'least' a 5th from todays price by 2020!.

Heck if they only go up by that much in 10 more years, I will be long out.
So that don't tell us much does it.

We really do need something to happen.

If you and I buy another million or 2 that should do the trick, greekman.
2517

I could go about another thousand quids worth, so if you can make the balance we are on.

That's a bit onesided so best left to someone else then.
2517

In answer to a post on iii re is the CardioQ technology not as good as it was thought, is it the management strategy that is holding sales back, or a bit of both I posted the following.

The Cardio system has been round for several years, not sure if its as long as 12, but if not it is heading that way.
Also as I posted not long back, other technologies are gaining on the deltex technology, and if they (deltex) don't get their finger out they will be left behind.
Technology is always being chased.
What next, another improvement say the CardioQ+, which would then have to go through several trials, which again would leave competitors another chance to overtake the Deltex system.
I am sure it is 'not' the product but the marketing strategy that is at fault as I just can't see any possibility of the 65 plus clinical trial reports being wrong.
These reports have consistently proven that the CardioQ saves, lives and money. What more can the customer ask for or want.
In the fable the tortoise always beats the hare. In the real world this just doesn't happen.
The management and investors have held onto the dream for far too long. We need to weigh up the cold hard facts and act now before our dream turns into a nightmare.

We are told we are nearing the finishing line, and yet the nearer we get the more nervous/frustrated I get.
My confidence should be growing, not wilting away.

Trading Statement.

Don't want to knock a company that has increased sales in all areas, but I am still somewhat doubtful that sufficient sales growth is available for them to make the deadline. The deadline to me being into profit before the money runs out.
I have allowed this share to make heart overrule head several times, so trying even more to look at the facts.
Still going to be a struggle, re the aforementioned deadline, but I must add, I am a tad more confident than I was before the trading update.
So for me it is still a hold.

It goes to show how interest in Deltex is waining. I would have expected far more posts following such a statement.

Still confident but due to this mornings sp feeling a bit negative.
Once again the sp is 1 step forward, 1 step back.
There have been as we know over 65 positive results re the CardioQ, resulting in an sp that has dropped over the last 8 years, 2002 = 26p/presently 10.25p. It must go to prove that substantial orders and nothing less will move the price.
It appears we could receive positive RNS's every day for a month and the only effect would be a temporary uplift followed by the usual, expected downside.
It goes to show that investors have become numb to such news.
It is a case of, 'Not another RNS' that does not state a large order.
Time and investors are running out. Management must do something.

I am a great fan of 'Dragons Den'.
Time after time we see people who have great ideas, projects or/and products. Their main problem by far is getting attention from prospective customers. Often the product is not known, as the initial task of getting the foot in the door has been impossible, but equally as often is when they do manage to get that door open, it is shut in their faces.
Enter the dragons!.
Same products, same doors, different marketing, for different read aggressive.
Probably an over simplification, as obviously Deltex are not an unknown individual, but a well established company but to my mind, the above analogy says it all.
Deltex need a dragon.

It looks like Deltex are a bit like this thread, just a couple of people (are you still there George) talking among themselves.

g
re your post 722. are they short of money? i have to confess i know a little but only a very little about fundamentals and such. EP taking share options in place of salary increase? or in place of salary? as you state the4 non exec and 1 exec have done so.
that to me is not a sign of confidence but more sign of cash shortage. but as i said i know little of such things. maybe someone might be able to shed some light on this.
that apart, a short term bounce might be in order according to the daily charts rsi divergance but i reiterate my post no.714 p36
i'm far from a dragon, but i'm out. until price proves itself.which is the same as the company proving itself.
good luck and regards
jkd
edit proving itself (capable that is)

Greekman--------yes still here, number 2 daughter got married last saturday so been otherwise occupied. Much that we have said about DEMG over the last few years is still relevant today, so I don't want to repeat myself. The choice is either stick with it (my option) or move on to other co's. Good luck
2517